A possible role of influenza virus in atherosclerosis-associated diseases: is prevention effective?
Abstract
The paper presents the literature data, as well as the results of our research on some aspects of the relationship between influenza infection and cardiovascular diseases. Influenza virus-induced endothelial dysfunction, modification of lipoprotein metabolism, atherosclerotic plaque outgrowth, and inflammation additionally support the opinion concerning the role of influenza infection as a strong cardiovascular risk factor. The feasibility of vaccination against these viruses is discussed because this might serve as an important tool for short- and long-term prevention of infection-associated cardiovascular disease.
About the Authors
O. V. Reshetnikov
RAMS
Russian Federation
Russian Federation
SB RAMS
Establishment of the Russian Academy of Medical Sciences Research Institute of Therapy
630089
st. Boris Bogatkov, 175/1
Novosibirsk
S. А. Kurilovich
RAMS
Russian Federation
Russian Federation
SB RAMS
Establishment of the Russian Academy of Medical Sciences Research Institute of Therapy
630089
st. Boris Bogatkov, 175/1
Novosibirsk
Yu. P. Nikitin
RAMS
Russian Federation
Russian Federation
SB RAMS
Establishment of the Russian Academy of Medical Sciences Research Institute of Therapy
630089
st. Boris Bogatkov, 175/1
Novosibirsk
References
1. Ross R. Atherosclerosis – an inflammatory disease // N. Engl. J. Med. 1999. Vol. 14. P. 115–126.
2. Шварц Я. Ш. Фиброзный процесс при атеросклерозе / Я. Ш. Шварц, Е. А. Чересиз // Атеросклероз. – 2011. – № 2. – С. 57–66.
3. Rosenfeld M. E., Campbell L. A. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis // Thromb. Haemost. 2011. Vol. 106. P. 858–867.
4. Жукова Ю. В. Современные представления об остром коронарном синдроме / Ю. В. Жукова, Ю. П. Никитин, В. И. Масычева // Бюл. СО РАМН. – 2008. – № 1. – С. 87–91.
5. Paoletti R., Gotto A. M. Jr., Hajjar D. P. Inflammation in atherosclerosis and implications for therapy // Circulation. 2004. Vol. 109. Suppl 1. P. 11120–11126.
6. Gatherer D. The 2009 H1N1 influenza outbreak in its historical context // J. Clin. Virol. 2009. Vol. 45. P. 174–178.
7. Lippi G., Franchini M., Favaloro E. J. Influenza and cardiovascular disease: does swine-origin, 2009 H1N1 flu virus represent a risk factor, an acute trigger, or both? // Semin. Thromb. Hemost. 2010. Vol. 36. P. 49–58.
8. Spencer F. A., Goldberg R. J., Becker R. C., Gore J. M. Seasonal distribution of acute myocardial infarction in the second national registry of myocardial infarction // J. Am. Coll. Cardiol. 1998. Vol. 31. P. 1226–1233.
9. Warren-Gash C., Bhaskaran K., Hayward A. et al. Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong // J. Infect. Dis. 2011. Vol. 203. P. 1710–1718.
10. Pettinen J., Valonen P. The risk of myocardial infarction among Finnish farmers seeking medical care for an infection // Am. J. Pub. Health. 1996. Vol. 86. P. 1440–1442.
11. Clayton T. C., Thompson M., Meade T. W. Recent respiratory infection and risk of cardiovascular disease: case-control study // Eur. Heart. J. 2008. Vol. 29. P. 96–103.
12. Siscovick D. S., Raghunathan T. E., Lin D. et al. Influenza vaccination and the risk of primary cardiac arrest // Am. J. Epidemiol. 2000. Vol. 152. P. 674–677.
13. Naghavi M., Barlas Z., Siadaty S. et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction // Circulation. 2000. Vol. 102. P. 3039–3045.
14. Lavallee P., Perchaud V., Gautier-Bertrand M. et al. Association between influenza vaccination and reduced risk of brain infarction // Stroke. 2002. Vol. 33. P. 513–518.
15. Gurfinkel E. P., Leon de la Fuente R., Mendiz O., Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study // Eur. Heart. J. 2004. Vol. 25. P. 25–31.
16. Никитин Ю. П. Ишемическая болезнь сердца, хламидийная и хеликобактерная инфекции: популяционное исследование / Ю. П. Никитин [и др.] // Кардиология. – 2000. – № 8. – С. 4–7.
17. Решетников О. В. Частота выявления некоторых инфекций у лиц с ишемической болезнью сердца / О. В. Решетников, С. К. Малютина, Ю. П. Никитин // Клинич. медицина. – 2008. – № 2. – С. 33–37.
18. Гуревич В. С. Инфекция вирусами гриппа при прогрессирующем атеросклерозе / В. С. Гуревич [и др.] // Кардиология. – 2002. – № 7. – С. 21–24.
19. Auer J., Leitinger M., Berent R. et al. Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography // Heart Dis. 2002. Vol. 4. P. 349–354.
20. Warren-Gash C., Smeeth L., Hayward A. C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review // Lancet. Infect. Dis. 2009. Vol. 9. P. 601–610.
21. Guan X., Yang W., Sun X. et al. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction // Inflamm. Res. 2012. Vol. 61. P. 591–598.
22. Плесков В. М. Виpусы гpиппа и атеpосклеpоз: pоль атеpосклеpотических бляшек в поддеpжании пеpсистентной фоpмы гpиппозной инфекции / В. М. Плесков [и др.] // Вестник РАМН. – 2003. – № 4. – С. 10–13.
23. Marchesi S., Lupattelli G., Lombardini R. et al. Acute inflammatory state during influenza infection and endothelial function // Atherosclerosis. 2005. Vol. 178. P. 345–350.
24. Van Lenten B. J., Wagner A. C., Anantharamaiah G. M. et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide // Circulation. 2002. Vol. 106. P. 1127–1132.
25. Keller T. T., van der Meer J. J., Teeling P. et al. Selective expansion of influenza A virus-specific T cells in symptomatic human carotid artery atherosclerotic plaques // Stroke. 2008. Vol. 39. P. 174–179.
26. Bouwman J. J., Visseren F. L., Bosch M. C. et al. Procoagulant and inflammatory response of virus-infected monocytes // Eur. J. Clin. Invest. 2002. Vol. 32. P. 759–766.
27. Madjid M., Naghavi M., Litovsky S., Casscells S. W. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies // Circulation. 2003. Vol. 108. P. 2730–2736.
28. Keller T., Weeda V. B., van Dongen C. J., Levi M. Influenza vaccines for preventing coronary heart disease // Cochrane. Database. Syst. Rev. 2008. 16. 3. CD005050.
29. Ciszewski A., Bilinska Z. T., Brydak L. B. et al. Infuenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study // Eur. Heart J. 2008. Vol. 29. P. 1350–1358.
30. Gwini S. M., Coupland C. A., Siriwardena A. N. The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study // Vaccine. 2011. Vol. 29. P. 1145–1149.
31. Casscells S. W., Granger E., Kress A. M. et al. Use of oseltamivir after infuenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system benefciaries with prior cardiovascular diseases // Circ. Cardiovasc. Qual. Outcomes. 2009. Vol. 2. 108–115.
Review
For citations:
Reshetnikov O.V., Kurilovich S.А., Nikitin Yu.P. A possible role of influenza virus in atherosclerosis-associated diseases: is prevention effective? Ateroscleroz. 2012;8(1):27-35. (In Russ.)
Views:
234
Email this article 